Hosted on MSN1mon
GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 BillionGSK stock rocketed Wednesday after the pharma titan raised its 2031 sales outlook to north of $50 billion. Please watch the video at Investors.com - The Weight-Loss Drug Market Is Hot. Which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback